Alzeca Biosciences develops best in class imaging technologies for the early detection of Alzheimer’s Disease pathology, focusing on improving patient selection and monitoring in clinical trials and differential diagnosis of Mild Cognitive Impairment
Alzeca Biosciences develops best in class imaging technologies for the early detection of Alzheimer’s Disease pathology, focusing on improving patient selection and monitoring in clinical trials and differential diagnosis of Mild Cognitive Impairment.